Search research articles
Contact Us
Filters
Showing results (81-90 of 162) with videos related to
Page
of 17
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)
|
December 7, 2018
Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
Bjørn-Eivind Kirsebom, Kaja Nordengen, Per Selnes, et al.
The Clinical Neuropsychologist
|
November 17, 2023
Regression-based normative data for the D-KEFS Color-Word Interference Test in Norwegian adults ages 20-85
Jacob Espenes, Ingrid Myrvoll Lorentzen, Ingvild Vøllo Eliassen, et al.
Clinical Chemistry and Laboratory Medicine
|
August 22, 2025
Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation
Burak Arslan, Ulf Andreasson, Elzbieta Rembeza, et al.
Frontiers in Neurology
|
September 28, 2020
Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial
Khadija Khalifa, Anne Katrine Bergland, Hogne Soennesyn, et al.
Scandinavian Journal of Psychology
|
September 18, 2023
Demographically adjusted Rey-Osterrieth Complex Figure Test norms in a Swedish and Norwegian cohort aged 49-77 years and comparison with North American norms
Fredrik Öhman, Marie Eckerström, Erik Hessen, et al.
Molecular Brain
|
May 29, 2016
Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease
Meryl S Lillenes, Alberto Rabano, Mari Støen, et al.
Ebiomedicine
|
February 21, 2025
Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer's disease
Robin Ziyue Zhou, Stefan Gaunitz, Bjørn-Eivind Kirsebom, et al.
Journal of Alzheimer'S Disease : JAD
|
November 29, 2012
Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment
Per Selnes, Dag Aarsland, Atle Bjørnerud, et al.
Applied Neuropsychology. Adult
|
June 18, 2025
Pathological biomarkers for Alzheimer's disease in cognitively unimpaired individuals are not associated with cognitive decline at two-year follow-up
Ingvild Vøllo Eliassen, Bjørn-Eivind Kirsebom, Knut Waterloo, et al.
Radiology
|
November 16, 2012
Mild cognitive impairment: cerebrospinal fluid tau biomarker pathologic levels and longitudinal changes in white matter integrity
Inge K Amlien, Anders M Fjell, Kristine B Walhovd, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 162) with videos related to
Sort By:
Page
of 17
Alzheimer'S & Dementia (New York, N. Y.)
|
December 7, 2018
Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
Bjørn-Eivind Kirsebom, Kaja Nordengen, Per Selnes, et al.
The Clinical Neuropsychologist
|
November 17, 2023
Regression-based normative data for the D-KEFS Color-Word Interference Test in Norwegian adults ages 20-85
Jacob Espenes, Ingrid Myrvoll Lorentzen, Ingvild Vøllo Eliassen, et al.
Clinical Chemistry and Laboratory Medicine
|
August 22, 2025
Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation
Burak Arslan, Ulf Andreasson, Elzbieta Rembeza, et al.
Frontiers in Neurology
|
September 28, 2020
Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial
Khadija Khalifa, Anne Katrine Bergland, Hogne Soennesyn, et al.
Scandinavian Journal of Psychology
|
September 18, 2023
Demographically adjusted Rey-Osterrieth Complex Figure Test norms in a Swedish and Norwegian cohort aged 49-77 years and comparison with North American norms
Fredrik Öhman, Marie Eckerström, Erik Hessen, et al.
Molecular Brain
|
May 29, 2016
Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease
Meryl S Lillenes, Alberto Rabano, Mari Støen, et al.
Ebiomedicine
|
February 21, 2025
Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer's disease
Robin Ziyue Zhou, Stefan Gaunitz, Bjørn-Eivind Kirsebom, et al.
Journal of Alzheimer'S Disease : JAD
|
November 29, 2012
Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment
Per Selnes, Dag Aarsland, Atle Bjørnerud, et al.
Applied Neuropsychology. Adult
|
June 18, 2025
Pathological biomarkers for Alzheimer's disease in cognitively unimpaired individuals are not associated with cognitive decline at two-year follow-up
Ingvild Vøllo Eliassen, Bjørn-Eivind Kirsebom, Knut Waterloo, et al.
Radiology
|
November 16, 2012
Mild cognitive impairment: cerebrospinal fluid tau biomarker pathologic levels and longitudinal changes in white matter integrity
Inge K Amlien, Anders M Fjell, Kristine B Walhovd, et al.
Page
of 17